Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia

ABSTRACT Adherence to imatinib mesylate improves clinical outcomes and promotes a reduction in health expenditure. However, treatment duration and lack of efficacy decrease adherence to pharmacotherapy, resulting in increased mortality associated with Chronic Myeloid Leukemia. This study aimed to ev...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Alexandra Rodrigues Alves, William Gustavo Lima, Michelly Martins Nagai, João Paulo Vilela Rodrigues, Lorena Rocha Ayres
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
Sarja:	Brazilian Journal of Pharmaceutical Sciences
Aiheet:	Chronic Myeloid Leukemia/treatment Imatinib Mesylate/treatment adherence Medication adherence Pharmacotheraphy review.
Linkit:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502016000400581&lng=en&tlng=en
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!